Category Archives: Pharmaceuticals

Study Suggests Revolutionary Drug Could Benefit Patients with Early Stage Alzheimer’s

A trial of a new Alzheimer’s drug has shown it could benefit patients in the earliest stages of the disease, raising hopes that a treatment for the devastating condition may… Read more »

Mylan Plans Generic EpiPen to Calm Pricing Outrage; Feels More Like a PR Move

Mylan NV’s latest attempt to deflect criticism over the price of allergy shot EpiPen failed to get the drugmaker out of the crosshairs of Congress this week. Last week, Chief… Read more »

Painted as the Latest Pharma Scoundrel, Mylan’s CEO Bresch Isn’t Buying It; She’s Got a Point, Maybe

Last week Mylan pharmaceuticals CEO Heather Bresch seemingly attained a status of villainy synonymous with Lance Armstrong and, more recently, Ryan Lochte, with news stories of its fourfold price increase… Read more »

Mylan to Reduce Cost of EpiPen as Pressure Mounts; Not All Patients to Benefit

Mylan NV (Amsterdam) on Thursday took some steps to alleviate patients’ cost burden for its $600 EpiPen emergency allergy shots following pressure from politicians including presidential candidate Hillary Clinton, who… Read more »

Drugmakers’ Pricing Power Helped by Exclusivity Rights: JAMA

The U.S., which spends more on drugs than any other country, might contain costs by limiting market exclusivity for brand-name medicines and changing coverage requirements for government health plans, some… Read more »

Pfizer Wins Bidding War for Medivation; But Why Bother?

Pharmaceutical giant Pfizer Inc. (New York City) is paying $14 billion to buy Medivation Inc. (San Francisco), a biotech company that sells a high-priced prostate cancer medication discovered by UCLA, according to the… Read more »

DEA Ignores the Evidence; Keeps Marijuana on Parity with Heroin

In a long-awaited announcement, the U.S. Drug Enforcement Administration denied requests to loosen the classification of marijuana as a dangerous drug with no medical use. The decision, reported by Reuters,… Read more »

Glaxo, Google Parent Create $715 Million Bioelectronic Medicines Venture

GlaxoSmithKline PLC (London) and Google parent Alphabet Inc. (Mountain View CA) have teamed up to develop what they call bioelectronic medicines, or treatments that use miniature implanted electronic devices to modify how electrical impulses are… Read more »

Valeant Plummets on Criminal Probe of Philidor Unit

Valeant Pharmaceuticals International Inc. (Laval Quebec) did an about-face and fell 11% on Thursday as new details about a criminal investigation into the drugmaker reignited investor concerns about the company’s… Read more »

Bristol-Myers’ Opdivo Fails in Key Lung-Cancer Study; Shares Plunge, as Do Patients’ Hopes

A cancer drug’s surprise failure in a clinical trial erased $20 billion from Bristol-Myers Squibb Co.’s (New York City) market value Friday, and raised serious questions about one of the industry’s… Read more »